Clinical Trials Browser

Phase 2 × L-BLP25 × Plasma cell × Clear all

NCT01094548 2016-02-22

Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy

Phase 2 Completed

34 enrolled 12 charts

Multiple Myeloma